Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Close price divided by the TTM earnings per share, excluding extraordinary items. TTM stands for trailing twelve months.
Close price divided by the book value per share at the end of the most recent financial year
Dividend Per Share for the most recent financial year divided by the close price
Average PE ratio of the sector the stock belongs to
Average PB ratio of the sector the stock belongs to
Average dividend yield of the sector the stock belongs to
GlaxoSmithKline Pharmaceuticals is a pharmaceutical company engaged in the business of manufacturing, distributing and trading in pharmaceuticals. The Co
Customise key metrics, see detailed forecasts, download stock data and more
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant
Special • Div/Share: ₹ 12
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant